Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» MELA Sciences Announces FDA Advisory Panel Votes Positively for MelaFind(R) on Safety, Efficacy and Risk/Benefit Ratio
MELA Sciences Announces FDA Advisory Panel Votes Positively for MelaFind(R) on Safety, Efficacy and Risk/Benefit Ratio
MELA Sciences Announces FDA Advisory Panel Votes Positively for MelaFind(R) on Safety, Efficacy and Risk/Benefit Ratio
Submitted by
moderatora
on November 19, 2010 - 7:54am
Source:
Yahoo/Marketwire
News Tags:
MELA Sciences
MelaFind
melanoma
skin cancer
dermatology
Headline:
MELA Sciences Announces FDA Advisory Panel Votes Positively for MelaFind(R) on Safety, Efficacy and Risk/Benefit Ratio
Do Not Allow Advertisers to Use My Personal information
